These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 27821627

  • 21. Prognostic relevance of clinical and histological features in IgA nephropathy treated with steroid and angiotensin receptor blockers.
    Choi S, Lee D, Jeong KH, Moon JY, Lee SH, Lee TW, Ihm CG.
    Clin Nephrol; 2009 Nov; 72(5):353-9. PubMed ID: 19863877
    [Abstract] [Full Text] [Related]

  • 22. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2017 Nov; 955():65-73. PubMed ID: 27718216
    [Abstract] [Full Text] [Related]

  • 23. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 24. Additive antiproteinuric effect of combination therapy with ACE inhibitor and angiotensin II receptor antagonist: differential short-term response between IgA nephropathy and diabetic nephropathy.
    Kim MJ, Song JH, Suh JH, Lee SW, Kim GA.
    Yonsei Med J; 2003 Jun 30; 44(3):463-72. PubMed ID: 12833584
    [Abstract] [Full Text] [Related]

  • 25. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan 30; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 26. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Sekizuka K, Ebihara I, Koide H.
    Am J Nephrol; 2000 Jan 30; 20(5):373-9. PubMed ID: 11092994
    [Abstract] [Full Text] [Related]

  • 27. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Jan 30; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 28. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
    Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T.
    J Am Soc Nephrol; 2007 Jun 30; 18(6):1880-8. PubMed ID: 17513327
    [Abstract] [Full Text] [Related]

  • 29. Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine.
    Kaneko T, Arai M, Ikeda M, Morita M, Watanabe Y, Hirama A, Shimizu A, Tsuruoka S.
    Int Urol Nephrol; 2015 Nov 30; 47(11):1823-30. PubMed ID: 26433884
    [Abstract] [Full Text] [Related]

  • 30. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.
    Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F.
    J Am Soc Nephrol; 2004 Jan 30; 15(1):157-63. PubMed ID: 14694168
    [Abstract] [Full Text] [Related]

  • 31. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Jan 30; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 32. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
    Manno C, Gesualdo L, D'Altri C, Rossini M, Grandaliano G, Schena FP.
    J Nephrol; 2001 Jan 30; 14(4):248-52. PubMed ID: 11506246
    [Abstract] [Full Text] [Related]

  • 33. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
    Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J, STOP-IgAN Investigators.
    N Engl J Med; 2015 Dec 03; 373(23):2225-36. PubMed ID: 26630142
    [Abstract] [Full Text] [Related]

  • 34. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053
    [Abstract] [Full Text] [Related]

  • 35. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 36. Reduced pre-pregnancy proteinuria is associated with improving postnatal maternal renal outcomes in IgA nephropathy women.
    Oh HJ, Han SH, Yoo DE, Kim SJ, Park JT, Kim JK, Yoo TH, Kang SW, Choi KH.
    Clin Nephrol; 2011 Dec 06; 76(6):447-54. PubMed ID: 22105447
    [Abstract] [Full Text] [Related]

  • 37. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb 06; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 38. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
    Kano K, Nishikura K, Yamada Y, Arisaka O.
    Clin Nephrol; 2003 Aug 06; 60(2):85-9. PubMed ID: 12940609
    [Abstract] [Full Text] [Related]

  • 39. Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
    Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, Nicastro M, Incerti M, Goldoni M, Trivioli G, Silvestri E, Mohammad AJ, Jayne D, Eriksson P, Segelmark M, Novikov P, Harris H, Roccatello D, Vaglio A.
    Arthritis Rheumatol; 2018 Jan 06; 70(1):109-114. PubMed ID: 28973844
    [Abstract] [Full Text] [Related]

  • 40. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.
    Donadio JV, Grande JP, Bergstralh EJ, Dart RA, Larson TS, Spencer DC.
    J Am Soc Nephrol; 1999 Aug 06; 10(8):1772-7. PubMed ID: 10446945
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.